SCHEMBL17084320

SCHEMBL17084320

CCCC1(CCC)c2cc(/C(=N/OC(C)=O)c3ccc(C(C)(C)C)cc3)ccc2-c2ccc([N+](=O)[O-])cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 4/20 0.39
▸ HPGD P15428 2/20 0.39
▸ MAPT P10636 8/20 0.37
▸ ALDH1A1 P00352 7/20 0.37
▸ LMNA P02545 5/20 0.37
▸ KMT2A Q03164 5/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ RAB9A P51151 4/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ ACHE P22303 1/20 0.34
▸ TDP1 Q9NUW8 2/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ POLB P06746 2/20 0.32
▸ MDM2 Q00987 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17056225 0.90 KMT2A (0.38) HTTMAPTALDH1A1LMNAKMT2A
SCHEMBL17084321 0.85 MAPT (0.36) HTTMAPTALDH1A1KMT2ARAB9A
SCHEMBL18122989 0.85 MAPT (0.36) HTTMAPTALDH1A1KMT2ARAB9A
SCHEMBL17056217 0.83 NPC1 (0.44) HTTHPGDMAPTALDH1A1LMNA
SCHEMBL18218064 0.83 NPC1 (0.44) HTTHPGDMAPTALDH1A1LMNA
SCHEMBL18848196 0.80 MAPT (0.35) HTTMAPTALDH1A1KMT2ARAB9A
SCHEMBL16556665 0.79 ESPL1 (0.38) HTTMAPTALDH1A1LMNAKMT2A
SCHEMBL29365660 0.79 ESPL1 (0.38) HTTMAPTALDH1A1LMNAKMT2A
SCHEMBL17084325 0.78 MAPT (0.41) HTTMAPTALDH1A1LMNAKMT2A
SCHEMBL17084341 0.78 MAPT (0.33) HTTMAPTALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9684238-B2 Fluorene-type compound, photopolymerization initiator comprising said fluorene-type compound, and photosensitive composition containing said photopolymerization initiator TOKYO OHKA KOGYO CO., LTD. (JP) 2017-06-20 — — US disclosed
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR DAITO CHEMIX CORPORATION (JP) 2015-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR AFF1, AFF2, FTO HTT 1962/4885HPGD 1651/4885MAPT 2875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback